The SPISE index is a surrogate marker for insulin resistance predicting emerging dysglycemia in children with overweight or obesity, and could, therefore, be applied to pediatric cohorts that lack direct insulin assessment. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.